Donald Abrams, MD
Dr. Abrams conducts clinical research of the use of cannabidiol for pain and symptom management, including for patients with sickle cell disease and chronic pain. He is also conducting an observational analysis of patients in San Francisco, San Diego and Chicago using cannabidiol-dominant products. Participants attending the integrative medicine center clinics in those cities as well as those at 3 dispensaries in each city to determine what they were using, how they were using it, for what and if it worked.
Stacey Anderson, PhD
Public health policy and social cognition focusing on investigating marketing strategies that tap implicit constructs of self and perceptions of others, pair brand identities with personal identities, and encourage consumption of products detrimental to individual and public health.
Dorie Apollonio, PhD
Health policy and tobacco control, particularly the ways that clinical research is translated into policy interventions and public knowledge.
Mehrdad Arjomandi, MD
Physiologic and inflammatory mechanisms of airway remodeling in various exposure-response models such as ozone-induced oxidative injury, allergic airway inflammation, and wood or tobacco smoke-induced airway injury.
John Balmes, MD
Respiratory and cardiovascular health effects of various air pollutants, focusing on the airway inflammatory effects of ozone, secondhand tobacco smoke, and wood smoke.
Neal Benowitz, MD
Human pharmacology of nicotine in relation to addiction and the pathogenesis of and individual differences in vulnerability to tobacco-related disease, and the use of pharmacologic data as a basis for public health policies to prevent and reduce such disease.
Stella Bialous, RN, DrPH, FAAN
WHO Framework Convention on Tobacco Control, tobacco industry monitoring and building nurses’ capacity for tobacco control nationally and internationally.
Paul Blanc, MD, MSPH
Toxic exposures and illness with focus on the role of environmental factors and disease prevention if factors were eliminated.
Esteban G. Burchard, MD, MPH
Identify and characterize genetic, environmental and social factors that predispose to asthma and modify drug response with special interest in how racially-specific genetic differences that modify disease and response to treatment.
Pages
Center Leadership
Pamela Ling, MD MPH
Director, Center for Tobacco Control Research & Education
Fellowship Program Director
Robert A. Hiatt, MD, PhD
Co-Director, Helen Diller Comprehensive Cancer Center Cancer Control Program
Tung T. Nguyen, MD
Co-Director, Helen Diller Comprehensive Cancer Center Cancer Control Program
Research Spotlight
AA and EA smokers undergo detailed monitoring of smoking behavior, receive known doses of nicotine to establish nicotine metabolic rate, undergo DNA testing, and have their responses to not smoking for several hours studied.
